Márquez E, Lucena M I, Andrade R J, González-Correa J A, Clavijo E, Lazo M D, Sánchez de la Cuesta F
Servicio de Farmacología Clínica, Hospital Universitario, Facultad de Medicina, Málaga.
Rev Clin Esp. 1992 Jun;191(2):76-9.
In the present publication we discuss nephrotoxicity (NT) incidence by reviewing all the clinical histories of one year (May 1989-May 1990) with diagnosis of obstructive jaundice or cholangitis. Of a total of 90 patients. 53 were treated with aminoglycosides and 37 received other antibiotics. Nephrotoxicity developed in nine patients of the group that received aminoglycosides (17%), versus only three patients (8%) in the other group. Both groups were comparable regarding sex, age and liver and renal basal functions. Analysis of the variables that could be associated with a higher incidence in the nephrotoxicity group that received aminoglycosides showed that there were no differences regarding age, sex, dosage, duration of treatment, plasmatic levels of aminoglycosides and liver and renal basal functions. Only simultaneous administration o furosemide was significantly associated with the development of nephrotoxicity. Results of this study underline the need of a prospective follow-up of patients with biliary obstruction during treatment with aminoglycosides. Meanwhile the evidence available allows us to recommend the monitoring of renal function in this type of patients.
在本出版物中,我们通过回顾1989年5月至1990年5月期间所有诊断为梗阻性黄疸或胆管炎的患者的临床病史,来探讨肾毒性(NT)的发生率。在总共90例患者中,53例接受了氨基糖苷类药物治疗,37例接受了其他抗生素治疗。接受氨基糖苷类药物治疗的组中有9例患者发生了肾毒性(17%),而另一组中只有3例患者(8%)发生了肾毒性。两组在性别、年龄以及肝肾功能基础方面具有可比性。对可能与接受氨基糖苷类药物治疗的肾毒性组中较高发生率相关的变量进行分析后发现,在年龄、性别、剂量、治疗持续时间、氨基糖苷类药物的血浆水平以及肝肾功能基础方面并无差异。只有同时使用速尿与肾毒性的发生显著相关。本研究结果强调了在氨基糖苷类药物治疗期间对胆道梗阻患者进行前瞻性随访的必要性。同时,现有证据使我们能够建议对这类患者的肾功能进行监测。